Haydale Graphene Industries Plc is a holding company, which engages in the sale and distribution of specialist research and development materials in the field of nano-technology. Its products include ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long-term data ...

Well VCP's amazing solution to take on 10% debt for their bonds was rejected by bond holders. I am sure most bond holders would have accepted the new terms, if they believe the debt could be paid in ...